Research Article
Autoantibodies against p53, MMP-7, and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers
Table 1
Details of the NMSC patients and normal controls.
| | Test parameter | Category | NMSC () | Normal () | | Cases | % | Cases | % |
| | Gender | Male | 56 | 55.4% | 50 | 49.0% | | Female | 45 | 44.6% | 52 | 51.0% |
| | Age at enrollment (years) | ≤60 | 16 | 15.8% | — | — | | 61-70 | 26 | 25.7% | — | — | | 71-80 | 37 | 36.6% | — | — | | 81-100 | 22 | 21.8% | — | — |
| | Histological type | Squamous cell carcinoma | 67 | 66.3% | — | — | | Basal cell carcinoma | 34 | 33.7% | — | — |
| | Site of tumor | Face/scalp/forehead | 50 | 49.5% | — | — | | Nose/ear/lip/eyelid | 31 | 30.7% | — | — | | Leg/arm/hand | 10 | 9.9% | — | — | | Others | 10 | 9.9% | — | — |
| | T category | T1 | 32 | 31.7% | — | — | | T2 | 37 | 36.6% | — | — | | T3 | 21 | 20.8% | — | — | | T4 | 11 | 10.9% | — | — |
| | Lymph node metastasis | Positive | 9 | 8.9% | — | — | | Negative | 92 | 91.1% | — | — |
| | TNM stage | I | 33 | 32.7% | — | — | | II | 36 | 35.6% | — | — | | III | 17 | 16.8% | — | — | | IV | 15 | 14.9% | — | — |
|
|
Note: NMSC: nonmelanoma skin cancer.
|
